We also tested the roles of FXa and PAR2 downstream of TF in eNOS-deficient mice [110], and showed that the administration of a FXa inhibitor improved nephrosclerosis and inflammatory markers in diabetic Akita mice lacking eNOS. Here, F10 is linked to nephrosclerosis.